---
title: "US FDA approves IDE for investigation of FLOWer embolic protection device"
date: "2025-10-02T11:02:31.000Z"
publishedDate: "2 octobre 2025"
summary: "AorticLab has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the FLOWer system pivotal clinical investigation. The FLOWer system is a full-body embolic protection device designed for use during transcatheter intracardiac procedures such as transcatheter aortic valve implantation (TAVI)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-approves-ide-for-investigation-of-flower-embolic-protection-device/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-10-02-us-fda-approves-ide-for-investigation-of-flower-embolic-protection-device"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/FLOWer-in-arch.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-approves-ide-for-investigation-of-flower-embolic-protection-device/"
---

![US FDA approves IDE for investigation of FLOWer embolic protection device](http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/FLOWer-in-arch.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-approves-ide-for-investigation-of-flower-embolic-protection-device/*

## L’essentiel

AorticLab has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the FLOWer system pivotal clinical investigation. The FLOWer system is a full-body embolic protection device designed for use during transcatheter intracardiac procedures such as transcatheter aortic valve implantation (TAVI).

## Lien source

https://cardiovascularnews.com/us-fda-approves-ide-for-investigation-of-flower-embolic-protection-device/
